Previous Article | Next Article 
Infection and Immunity, September 2005, p. 5645-5653, Vol. 73, No. 9
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.9.5645-5653.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Early Cytokine Production Is Associated with Protection from Murine Cerebral Malaria
Andrew J. Mitchell,1,
Anna M. Hansen,1,2,
Leia Hee,1
Helen J. Ball,1
Sarah M. Potter,1,
John C. Walker,2 and
Nicholas H. Hunt1*
Departments of Pathology,1
Medicine, University of Sydney, Sydney, Australia2
Received 21 December 2004/
Returned for modification 18 February 2005/
Accepted 9 May 2005
Cerebral malaria (CM) is an infrequent but serious complication of Plasmodium falciparum infection in humans. Animal and human studies suggest that the pathogenesis of CM is immune mediated, but the precise mechanisms leading to cerebral pathology are unclear. In mice, infection with Plasmodium berghei ANKA results in CM on day 6 postinoculation (p.i.), while infection with the closely related strain P. berghei K173 does not result in CM. Infection with P. berghei K173 was associated with increased plasma gamma interferon (IFN-
) at 24 h p.i. and with increased splenic and hepatic mRNAs for a range of cytokines (IFN-
, interleukin-10 [IL-10], and IL-12) as well as the immunoregulatory enzyme indoleamine 2,3-dioxygenase. In contrast, P. berghei ANKA infection was associated with an absence of cytokine production at 24 h p.i. but a surge of IFN-
production at 3 to 4 days p.i. When mice were coinfected with both ANKA and K173, they produced an early cytokine response, including a burst of IFN-
at 24 h p.i., in a manner similar to animals infected with P. berghei K173 alone. These coinfected mice failed to develop CM. In addition, in a low-dose P. berghei K173 infection model, protection from CM was associated with early production of IFN-
. Early IFN-
production was present in NK-cell-depleted, 
-cell-depleted, and J
281/ (NKT-cell-deficient) mice but absent from ß2-microglobulin mice that had been infected with P. berghei K173. Taken together, the results suggest that the absence of a regulatory pathway involving IFN-
and CD8+ T cells in P. berghei ANKA infection allows the development of cerebral immunopathology.
* Corresponding author. Mailing address: University of Sydney, Department of Pathology, Medical Foundation Building (K25), 92-94 Parramatta Rd., Camperdown NSW 2042, Australia. Phone: 61-2-9036 3242. Fax: 61-2-9036 3286. E-mail:
nhunt{at}med.usyd.edu.au.
Editor: J. F. Urban, Jr.
A.J.M. and A.M.H. contributed equally to the work in this paper.
Present address: Département d'Immunologie, Institut Cochin, Institut National de la Santé et da la Recherche Médicale Unité 567, Paris, France.
Infection and Immunity, September 2005, p. 5645-5653, Vol. 73, No. 9
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.9.5645-5653.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Metenou, S., Dembele, B., Konate, S., Dolo, H., Coulibaly, S. Y., Coulibaly, Y. I., Diallo, A. A., Soumaoro, L., Coulibaly, M. E., Sanogo, D., Doumbia, S. S., Wagner, M., Traore, S. F., Klion, A., Mahanty, S., Nutman, T. B.
(2009). Patent Filarial Infection Modulates Malaria-Specific Type 1 Cytokine Responses in an IL-10-Dependent Manner in a Filaria/Malaria-Coinfected Population. J. Immunol.
183: 916-924
[Abstract]
[Full Text]
-
Finney, C. A. M., Lu, Z., LeBourhis, L., Philpott, D. J., Kain, K. C.
(2009). Disruption of Nod-like Receptors Alters Inflammatory Response to Infection but Does Not Confer Protection in Experimental Cerebral Malaria. Am J Trop Med Hyg
80: 718-722
[Abstract]
[Full Text]
-
Niikura, M., Kamiya, S., Kita, K., Kobayashi, F.
(2008). Coinfection with Nonlethal Murine Malaria Parasites Suppresses Pathogenesis Caused by Plasmodium berghei NK65. J. Immunol.
180: 6877-6884
[Abstract]
[Full Text]
-
Patel, S. N., Berghout, J., Lovegrove, F. E., Ayi, K., Conroy, A., Serghides, L., Min-oo, G., Gowda, D. C., Sarma, J. V., Rittirsch, D., Ward, P. A., Liles, W. C., Gros, P., Kain, K. C.
(2008). C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. JEM
205: 1133-1143
[Abstract]
[Full Text]
-
Miu, J., Hunt, N. H., Ball, H. J.
(2008). Predominance of Interferon-Related Responses in the Brain during Murine Malaria, as Identified by Microarray Analysis. Infect. Immun.
76: 1812-1824
[Abstract]
[Full Text]
-
Miu, J., Mitchell, A. J., Muller, M., Carter, S. L., Manders, P. M., McQuillan, J. A., Saunders, B. M., Ball, H. J., Lu, B., Campbell, I. L., Hunt, N. H.
(2008). Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency. J. Immunol.
180: 1217-1230
[Abstract]
[Full Text]
-
Couper, K. N., Blount, D. G., Hafalla, J. C. R., van Rooijen, N., de Souza, J. B., Riley, E. M.
(2007). Macrophage-Mediated but Gamma Interferon-Independent Innate Immune Responses Control the Primary Wave of Plasmodium yoelii Parasitemia. Infect. Immun.
75: 5806-5818
[Abstract]
[Full Text]
-
Lovegrove, F. E., Gharib, S. A., Patel, S. N., Hawkes, C. A., Kain, K. C., Liles, W. C.
(2007). Expression Microarray Analysis Implicates Apoptosis and Interferon-Responsive Mechanisms in Susceptibility to Experimental Cerebral Malaria. Am. J. Pathol.
171: 1894-1903
[Abstract]
[Full Text]
-
Roque, S., Nobrega, C., Appelberg, R., Correia-Neves, M.
(2007). IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy. J. Immunol.
178: 8028-8035
[Abstract]
[Full Text]
-
Vigario, A. M., Belnoue, E., Gruner, A. C., Mauduit, M., Kayibanda, M., Deschemin, J.-C., Marussig, M., Snounou, G., Mazier, D., Gresser, I., Renia, L.
(2007). Recombinant Human IFN-{alpha} Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice. J. Immunol.
178: 6416-6425
[Abstract]
[Full Text]
-
Patel, S. N., Lu, Z., Ayi, K., Serghides, L., Gowda, D. C., Kain, K. C.
(2007). Disruption of CD36 Impairs Cytokine Response to Plasmodium falciparum Glycosylphosphatidylinositol and Confers Susceptibility to Severe and Fatal Malaria In Vivo. J. Immunol.
178: 3954-3961
[Abstract]
[Full Text]